Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Nat Chem Biol
2008 Feb 01;42:119-25. doi: 10.1038/nchembio.63.
Show Gene links
Show Anatomy links
A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex.
Dupré A
,
Boyer-Chatenet L
,
Sattler RM
,
Modi AP
,
Lee JH
,
Nicolette ML
,
Kopelovich L
,
Jasin M
,
Baer R
,
Paull TT
,
Gautier J
.
???displayArticle.abstract???
The MRN (Mre11-Rad50-Nbs1)-ATM (ataxia-telangiectasia mutated) pathway is essential for sensing and signaling from DNA double-strand breaks. The MRN complex acts as a DNA damage sensor, maintains genome stability during DNA replication, promotes homology-dependent DNA repair and activates ATM. MRN is essential for cell viability, which has limited functional studies of the complex. Small-molecule inhibitors of MRN could circumvent this experimental limitation and could also be used as cellular radio- and chemosensitization compounds. Using cell-free systems that recapitulate faithfully the MRN-ATM signaling pathway, we designed a forward chemical genetic screen to identify inhibitors of the pathway, and we isolated 6-(4-hydroxyphenyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone (mirin, 1) as an inhibitor of MRN. Mirin prevents MRN-dependent activation of ATM without affecting ATM protein kinase activity, and it inhibits Mre11-associated exonuclease activity. Consistent with its ability to target the MRN complex, mirin abolishes the G2/M checkpoint and homology-dependent repair in mammalian cells.
Arthur,
Structural and functional analysis of Mre11-3.
2004, Pubmed
Arthur,
Structural and functional analysis of Mre11-3.
2004,
Pubmed
Bakkenist,
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.
2003,
Pubmed
Bhaskara,
Rad50 adenylate kinase activity regulates DNA tethering by Mre11/Rad50 complexes.
2007,
Pubmed
,
Xenbase
Carson,
The Mre11 complex is required for ATM activation and the G2/M checkpoint.
2003,
Pubmed
Cimprich,
cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein.
1996,
Pubmed
Costanzo,
Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage.
2000,
Pubmed
,
Xenbase
Costanzo,
Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication.
2001,
Pubmed
,
Xenbase
Costanzo,
Mre11 assembles linear DNA fragments into DNA damage signaling complexes.
2004,
Pubmed
,
Xenbase
D'Amours,
The Mre11 complex: at the crossroads of dna repair and checkpoint signalling.
2002,
Pubmed
Difilippantonio,
Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models.
2005,
Pubmed
Dupré,
Two-step activation of ATM by DNA and the Mre11-Rad50-Nbs1 complex.
2006,
Pubmed
,
Xenbase
Esashi,
CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair.
2005,
Pubmed
Falck,
Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage.
2005,
Pubmed
Garner,
Corrected structure of mirin, a small-molecule inhibitor of the Mre11-Rad50-Nbs1 complex.
2009,
Pubmed
Gatei,
ATM-dependent phosphorylation of nibrin in response to radiation exposure.
2000,
Pubmed
Haber,
The many interfaces of Mre11.
1998,
Pubmed
Hickson,
Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.
2004,
Pubmed
Kastan,
Cell-cycle checkpoints and cancer.
2004,
Pubmed
Kitagawa,
Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway.
2004,
Pubmed
Komarov,
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.
1999,
Pubmed
Kozlov,
Involvement of novel autophosphorylation sites in ATM activation.
2006,
Pubmed
Lavin,
ATM signaling and genomic stability in response to DNA damage.
2005,
Pubmed
Lee,
Purification and biochemical characterization of ataxia-telangiectasia mutated and Mre11/Rad50/Nbs1.
2006,
Pubmed
Lee,
Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex.
2004,
Pubmed
Lee,
ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex.
2005,
Pubmed
Mayer,
Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen.
1999,
Pubmed
,
Xenbase
Paull,
The 3' to 5' exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks.
1998,
Pubmed
Paull,
The Mre11/Rad50/Nbs1 complex and its role as a DNA double-strand break sensor for ATM.
2005,
Pubmed
Peterson,
A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions.
2001,
Pubmed
,
Xenbase
Pierce,
XRCC3 promotes homology-directed repair of DNA damage in mammalian cells.
1999,
Pubmed
Shiloh,
ATM and related protein kinases: safeguarding genome integrity.
2003,
Pubmed
Smythe,
Systems for the study of nuclear assembly, DNA replication, and nuclear breakdown in Xenopus laevis egg extracts.
1991,
Pubmed
,
Xenbase
Stivers,
Small molecule versus DNA repair nanomachine.
2008,
Pubmed
Symington,
Role of RAD52 epistasis group genes in homologous recombination and double-strand break repair.
2002,
Pubmed
Trenz,
ATM and ATR promote Mre11 dependent restart of collapsed replication forks and prevent accumulation of DNA breaks.
2006,
Pubmed
,
Xenbase
Uziel,
Requirement of the MRN complex for ATM activation by DNA damage.
2003,
Pubmed
Verma,
Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain.
2004,
Pubmed
,
Xenbase
Wignall,
Identification of a novel protein regulating microtubule stability through a chemical approach.
2004,
Pubmed
,
Xenbase
You,
ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1.
2005,
Pubmed
,
Xenbase
Zhou,
Targeting the checkpoint kinases: chemosensitization versus chemoprotection.
2004,
Pubmed
Zhou,
The DNA damage response: putting checkpoints in perspective.
2000,
Pubmed
